Pestalozzi advises Johnson & Johnson's subsidiary DePuy Orthopaedics, Inc. on its divestiture of its trauma business to Biomet
Johnson & Johnson's subsidiary DePuy Orthopaedics, Inc. has entered into an agreement to divest its trauma business to Biomet, Inc. following to Johnson & Johnson's acquisition of Synthes Inc. The divestiture is expected to close in the second quarter 2012. Johnson & Johnson was advised as to Swiss law by Pestalozzi on this transaction.